Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Weiss: Protection by Neutralizing Antibodies |
| Strategy: | Protein & peptide vaccines |
| Study Type: | Pre-Clinical Non-NHP |
| Species: | Rabbit |
| Stage: | Assays Completed |
| Study Start Date: | 2007-10-25 |
| Study Made Public: | NA |
Title
Screen for neutralizing antibodies induced by gp41-HA immunization
Description
CAVD 288 is a preclinical rabbit study to assess a novel gp41 construct (HA-gp41) for its ability to induce neutralizing antibodies in rabbits.
Sign in to see full information about this study and to download study data.
Products
Product info coming soon!Integrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.